New European Leadership Backpedals: EU Device Oversight Will Stay In Health Division
This article was originally published in The Gray Sheet
Executive Summary
The incoming president of the European Commission has reversed a decision that would have moved EU oversight of medical device and drug policy issues from the health division to the markets/industry division following criticism from lawmakers and health care advocates.